Capital Advisors, Ltd. LLC Kura Oncology, Inc. Transaction History
Capital Advisors, Ltd. LLC
- $811 Million
- Q2 2025
A detailed history of Capital Advisors, Ltd. LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 13 shares of KURA stock, worth $80. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13Holding current value
$80% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KURA
# of Institutions
191Shares Held
79.4MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$48.1 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$46.1 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$43.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$40.7 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$33.2 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $415M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...